Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Medium-dose estrogen ameliorates experimental autoimmune encephalomyelitis in ovariectomized mice.
Disease-Modifying Drug Possibly Linked to Placental Insufficiency: Severe placental complications in a pregnant woman with multiple sclerosis.
A case of POEMS mimicking a "Guillain-Barré like" syndrome.
Adenosine A1-Receptors Modulate mTOR Signaling to Regulate White Matter Inflammatory Lesions Induced by Chronic Cerebral Hypoperfusion.
The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system.
Polygenic control of autoimmune peripheral nerve inflammation in rat.
Vitamin D as an immune modulator in multiple sclerosis, a review.
The use of clinically approved small particles of iron oxide (SPIO) for labeling of mesenchymal stem cells aggravates clinical symptoms in experimental autoimmune encephalomyelitis and influences their in vivo distribution.
Brain stiffness increases with myelin content.
Terminal complement activation is increased and associated with disease severity in CIDP.
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Navarra, Gipuzkoa and La Rioja].
Optical Coherence Tomography for the Neurologist.
Microglia and neurons in the hippocampus of migratory sandpipers.
Gait characteristics according to pyramidal, sensory and cerebellar EDSS subcategories in people with multiple sclerosis.
Short commentary on 'a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking'.
From HBV to HPV: Designing vaccines for extensive and intensive vaccination campaigns worldwide.
Modeling Chronic Traumatic Encephalopathy: The Way Forward for Future Discovery.
Long-term functional results of aspiration and sclerotherapy with ethanol in patients with autosomal dominant polycystic kidney disease: a non-randomized pilot clinical study.
Unveiling alterative splice diversity from human oligodendrocyte proteome data.
Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor.
The relation of multiple sclerosis with allergy and atopy: a case control study.
Epidemiology of Major Neurodegenerative Diseases in Women: Contribution of the Nurses' Health Study.
Erratum to: IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
B cells of multiple sclerosis patients induce autoreactive proinflammatory T cell responses.
Clinical Reasoning: Bacterial meningitis causing a neuromyelitis optica flare.
Pages
« first
‹ previous
…
747
748
749
750
751
752
753
754
755
…
next ›
last »